Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12707934rdf:typepubmed:Citationlld:pubmed
pubmed-article:12707934lifeskim:mentionsumls-concept:C0920317lld:lifeskim
pubmed-article:12707934lifeskim:mentionsumls-concept:C0058698lld:lifeskim
pubmed-article:12707934lifeskim:mentionsumls-concept:C0036341lld:lifeskim
pubmed-article:12707934lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:12707934lifeskim:mentionsumls-concept:C1335671lld:lifeskim
pubmed-article:12707934lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:12707934lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:12707934pubmed:issue1lld:pubmed
pubmed-article:12707934pubmed:dateCreated2003-4-22lld:pubmed
pubmed-article:12707934pubmed:abstractTextAn association has been reported between a dopamine D(2) receptor gene (DRD2) Ser311Cys variant and schizophrenia. In a replication attempt, Swedish patients with schizophrenia (n = 173) and control subjects (n = 236) were assessed for the DRD2 Ser311Cys variant. Schizophrenic patients displayed higher Cys311 allele frequencies than control subjects (4.0 vs. 0.8%, chi(2) = 9.49, df = 1, P = 0.002; odds ratio (OR) 4.93, 95% confidence interval (95% CI) 1.61-15.12). The association was detected only in men. The results were supported by a meta-analysis of all published case-control studies comprising a total of 9,152 subjects (chi(2) = 11.37, df = 1, P < 0.001; OR 1.43, 95% CI 1.16-1.78). The present results support the involvement of the DRD2 gene in the pathogenesis of schizophrenia.lld:pubmed
pubmed-article:12707934pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12707934pubmed:languageenglld:pubmed
pubmed-article:12707934pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12707934pubmed:citationSubsetIMlld:pubmed
pubmed-article:12707934pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12707934pubmed:statusMEDLINElld:pubmed
pubmed-article:12707934pubmed:monthMaylld:pubmed
pubmed-article:12707934pubmed:issn1552-4841lld:pubmed
pubmed-article:12707934pubmed:authorpubmed-author:SedvallGöran...lld:pubmed
pubmed-article:12707934pubmed:authorpubmed-author:TereniusLarsLlld:pubmed
pubmed-article:12707934pubmed:authorpubmed-author:JönssonErik...lld:pubmed
pubmed-article:12707934pubmed:authorpubmed-author:SillénAnnaAlld:pubmed
pubmed-article:12707934pubmed:authorpubmed-author:VaresMariaMlld:pubmed
pubmed-article:12707934pubmed:authorpubmed-author:EkholmBirgitBlld:pubmed
pubmed-article:12707934pubmed:copyrightInfoCopyright 2003 Wiley-Liss, Inc.lld:pubmed
pubmed-article:12707934pubmed:issnTypePrintlld:pubmed
pubmed-article:12707934pubmed:day15lld:pubmed
pubmed-article:12707934pubmed:volume119Blld:pubmed
pubmed-article:12707934pubmed:ownerNLMlld:pubmed
pubmed-article:12707934pubmed:authorsCompleteYlld:pubmed
pubmed-article:12707934pubmed:pagination28-34lld:pubmed
pubmed-article:12707934pubmed:dateRevised2008-5-21lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:meshHeadingpubmed-meshheading:12707934...lld:pubmed
pubmed-article:12707934pubmed:year2003lld:pubmed
pubmed-article:12707934pubmed:articleTitleDopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis.lld:pubmed
pubmed-article:12707934pubmed:affiliationDepartment of Clinical Neuroscience, HUBIN Project, Karolinska Institutet and Hospital, Stockholm, Sweden. erikj@ks.selld:pubmed
pubmed-article:12707934pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12707934pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12707934pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12707934pubmed:publicationTypeMeta-Analysislld:pubmed
entrez-gene:1813entrezgene:pubmedpubmed-article:12707934lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12707934lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12707934lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12707934lld:pubmed